Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer

Official record

Identifier

NCT07528430

Recruiting locations

country

United States

Interventions studied

Not provided in the official record

Lead sponsor

University of Maryland, Baltimore

Target enrolment

450 participants

Study type

OBSERVATIONAL

Phase

Not provided in the official record

Status

Not yet recruiting

First posted

Apr 14, 2026

Last updated on the registry

Jul 29, 2026

Age

18 Years

Sex

ALL

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* 18 years old or older
* Patient of UMMS
* Willing and able to consent to study procedures listed in the protocol
* Ability to speak and understand English
* Has a history of pancreatic cancer of is at high risk for pancreatic cancer

Exclusion Criteria:

* Younger than 18 years old
* Patient not cared for at UMMS
* Unable to consent to study procedures listed in the protocol
* Unable to speak or understand English
* Does not have a history of pancreatic cancer or is not at high risk for pancreatic cancer